{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:33:55Z","timestamp":1786988035024,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T00:00:00Z","timestamp":1662249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejca.2022.08.032","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T14:56:53Z","timestamp":1664204213000},"page":"291-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Age trends in biliary tract cancer incidence by anatomical subtype: A Swedish cohort study"],"prefix":"10.1016","volume":"175","author":[{"given":"Rithva","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-5602","authenticated-orcid":false,"given":"Jonas F.","family":"Ludvigsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"von Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5143-5448","authenticated-orcid":false,"given":"Jesper","family":"Lagergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3858-6241","authenticated-orcid":false,"given":"Annika","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0683-1537","authenticated-orcid":false,"given":"Cecilia","family":"Radkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2022.08.032_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.suc.2014.01.009","article-title":"Gallbladder cancer","volume":"94","author":"Wernberg","year":"2014","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.ejca.2022.08.032_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bpg.2015.02.003","article-title":"Epidemiology of cholangiocarcinoma","volume":"29","author":"Bergquist","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.ejca.2022.08.032_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jss.2019.07.031","article-title":"Geographical and temporal variation in the incidence and mortality of hepato-pancreato-biliary primary malignancies:1990-2017","volume":"245","author":"Weaver","year":"2020","journal-title":"J Surg Res"},{"key":"10.1016\/j.ejca.2022.08.032_bib4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2022.08.032_bib5","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejca.2022.08.032_bib6","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/jhbp.1001","article-title":"Obesity and cholangiocarcinoma: a review of epidemiological and molecular associations","volume":"28","author":"Osataphan","year":"2021","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.ejca.2022.08.032_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","volume":"8","author":"Blechacz","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2022.08.032_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.suc.2018.12.008","article-title":"Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies","volume":"99","author":"Hickman","year":"2019","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.ejca.2022.08.032_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2017.07.013","article-title":"Sex differences in cancer risk and survival: a Swedish cohort study","volume":"84","author":"Radkiewicz","year":"2017","journal-title":"Eur J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2022.08.032_bib10","first-page":"19","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int J Int Assoc Study Liver"},{"key":"10.1016\/j.ejca.2022.08.032_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejca.2022.08.032_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejca.2022.08.032_bib13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncol"},{"key":"10.1016\/j.ejca.2022.08.032_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.6004\/jnccn.2017.7056","article-title":"Trends in incidence and factors affecting survival of patients with cholangiocarcinoma in the United States","volume":"16","author":"Mukkamalla","year":"2018","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejca.2022.08.032_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.canep.2018.06.004","article-title":"The population-based incidence and mortality of biliary tract cancer in Sweden","volume":"56","author":"Kilander","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejca.2022.08.032_bib16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5604\/01.3001.0010.8659","article-title":"Racial, ethnic, and age disparities in incidence and survival of intrahepatic cholangiocarcinoma in the United States; 1995-2014","volume":"17","author":"Antwi","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ejca.2022.08.032_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1477-2574.2012.00536.x","article-title":"Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival","volume":"14","author":"Witjes","year":"2012","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.ejca.2022.08.032_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2188\/jea.JE20130122","article-title":"Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan","volume":"24","author":"Utada","year":"2014","journal-title":"J Epidemiol"},{"key":"10.1016\/j.ejca.2022.08.032_bib19","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1158\/1055-9965.EPI-15-0199","article-title":"Gallbladder cancer incidence and mortality, United States 1999-2011","volume":"24","author":"Henley","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2022.08.032_bib20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/cncr.31942","article-title":"Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013","volume":"125","author":"Van Dyke","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.08.032_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.canep.2018.04.011","article-title":"Analysis of incidence, mortality and survival for pancreatic and biliary tract cancers across Europe, with assessment of influence of revised European age standardisation on estimates","volume":"55","author":"Minicozzi","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejca.2022.08.032_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2022.08.032_bib23","first-page":"280","article-title":"Declining cancer incidence in the elderly: decreasing diagnostic intensity or biology?","volume":"31","author":"Radkiewicz","year":"2022","journal-title":"Cancer Epidemiol Biomark Prevent Publ Am Assoc Cancer Res"},{"key":"10.1016\/j.ejca.2022.08.032_bib24","series-title":"Constance percy, valerie van Holten, Calum Muir","article-title":"International classification of diseases for oncology\/editors","author":"Percy","year":"1990"},{"key":"10.1016\/j.ejca.2022.08.032_bib25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jnci\/djj234","article-title":"Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States","volume":"98","author":"Welzel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2022.08.032_bib26","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3109\/0284186X.2013.857429","article-title":"Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers","volume":"53","author":"Kilander","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2022.08.032_bib27","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/s41416-022-01704-x","article-title":"Incidence trends for twelve cancers in younger adults-a rapid review","volume":"126","author":"di Martino","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2022.08.032_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/00365521.2015.1111935","article-title":"Regional variations in cholecystectomy rates in Sweden: impact on complications of gallstone disease","volume":"51","author":"Noel","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejca.2022.08.032_bib29","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ueg2.12154","article-title":"Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland","volume":"9","author":"Barner-Rasmussen","year":"2021","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.ejca.2022.08.032_bib30","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry","volume":"76(5)","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejca.2022.08.032_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90175-w","article-title":"Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies","volume":"11","author":"Aune","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2022.08.032_bib32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2008.02.017","article-title":"Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study","volume":"48","author":"Card","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejca.2022.08.032_bib33","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2022.08.032_bib34","first-page":"293","article-title":"Primary sclerosing cholangitis, Part 1: epidemiology, etiopathogenesis, clinical features, and treatment","volume":"14","author":"Tabibian","year":"2018","journal-title":"Gastroenterol Hepatol (N Y)."},{"key":"10.1016\/j.ejca.2022.08.032_bib35","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejca.2022.08.032_bib36","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejca.2022.08.032_bib37","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2017.16071","article-title":"Association between use of thiopurines or tumor necrosis factor Antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease","volume":"318","author":"Lemaitre","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2022.08.032_bib38","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2016.04.039","article-title":"Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis","volume":"14","author":"Bonovas","year":"2016","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922005251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922005251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:39:15Z","timestamp":1760733555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922005251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":38,"alternative-id":["S0959804922005251"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.08.032","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age trends in biliary tract cancer incidence by anatomical subtype: A Swedish cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}